The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry
Open accessAbstract
BACKGROUND: Brugada syndrome is characterized by ST-segment elevation in the right precordial leads and an increased risk of sudden cardiac death (SCD). Fundamental questions remain on the best strategy for assessing the real disease-associated arrhythmic risk, especially in asymptomatic patients. The aim of the present study was to evaluate the prognosis and risk factors of SCD in Brugada syndrome patients in the FINGER (France, Italy, Netherlands, Germany) Brugada syndrome registry. METHODS AND RESULTS: Patients were recruited in 11 tertiary centers in 4 European countries. Inclusion criteria consisted of a type 1 ECG present either at baseline or after drug challenge, after exclusion of diseases that mimic Brugada syndrome. The registry included 1029 consecutive individuals (745 men; 72%) with a median age of 45 (35 to 55) years. Diagnosis was based on (1) aborted SCD (6%); (2) syncope, otherwise unexplained (30%); and (3) asymptomatic patients (64%). During a median follow-up of 31.9 (14 to 54.4) months, 51 cardiac events (5%) occurred (44 patients experienced appropriate implantable cardioverter-defibrillator shocks, and 7 died suddenly). The cardiac event rate per year was 7.7% in patients with aborted SCD, 1.9% in patients with syncope, and 0.5% in asymptomatic patients. Symptoms and spontaneous type 1 ECG were predictors of arrhythmic events, whereas gender, familial history of SCD, inducibility of ventricular tachyarrhythmias during electrophysiological study, and the presence of an SCN5A mutation were not predictive of arrhythmic events. CONCLUSIONS: In the largest series of Brugada syndrome patients thus far, event rates in asymptomatic patients were low. Inducibility of ventricular tachyarrhythmia and family history of SCD were not predictors of cardiac events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, a history of syncope in patients with structural heart disease or inheritable arrhythmia syndromes is associated with a two- to four-fold increased risk of death, 348,350-353 but varies between specific conditions. 354-356”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [353]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the largest registry (1029 patients), the incidence of arrhythmic events (sustained VT or VF, appropriate ICD therapy, or sudden death) in patients with Brugada syndrome was 7.7% per year in those with a history of sudden cardiac arrest, 1.9% per year with syncope, and 0.5% per year in asymptomatic patients. 353”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [353]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ahistory of syncope may increase the risk of arrhythmic events up to two- to three-fold compared with that in asymptomatic patients.”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [353]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brugada, P., & Brugada, J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90253-j · Cited by 3,344
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
Chen, Q., Kirsch, G. E., Zhang, D., Brugada, R., Brugada, J., Brugada, P., Potenza, D. R., Moya‐Mitjans, À., Borggrefe, M., BREITHARDT, G. E., et al. (1998) · Nature · doi:10.1038/32675 · Cited by 1,823
Self-citationNatural History of Brugada Syndrome
Priori, S. G., Napolitano, C., Gasparini, M., Pappone, C., Bella, P. E. D., Giordano, U., Bloise, R., Giustetto, C., Nardis, R. D., Grillo, M., et al. (2002) · Circulation · doi:10.1161/hc1102.105288 · Cited by 1,030
Self-citationAntzelevitch, C., Pollevick, G. D., Cordeiro, J. M., Casis, O., Sanguinetti, M. C., Aizawa, Y., Guerchicoff, A., Pfeiffer, R., Oliva, A., Wollnik, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.668392 · Cited by 933
Self-citationBrugada, J., Brugada, R., Antzelevitch, C. N., Towbin, J. A., Nademanee, K., & Brugada, P. (2002) · Circulation · doi:10.1161/hc0102.101354 · Cited by 624
Brugada Syndrome: Report of the Second Consensus Conference
(2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.01.005 · Cited by 609
Self-citationBrugada, J., Brugada, R., & Brugada, P. (2003) · Circulation · doi:10.1161/01.cir.0000104568.13957.4f · Cited by 546
Watanabe, H., Koopmann, T., Scouarnec, S. L., Yang, T., Ingram, C. R., Schott, J., Demolombe, S., Probst, V., Anselme, F., Escande, D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33891 · Cited by 507
Self-citationEfficacy of Quinidine in High-Risk Patients With Brugada Syndrome
Belhassen, B., Glick, A., & Viskin, S. (2004) · Circulation · doi:10.1161/01.cir.0000143159.30585.90 · Cited by 490
Long-Term Prognosis of Individuals With Right Precordial ST-Segment–Elevation Brugada Syndrome
Eckardt, L., Probst, V., Smits, J. P. P., Schulze‐Bahr, E., Wolpert, C., Schimpf, R., Wichter, T., Boisseau, P., Heinecke, A., BREITHARDT, G. E., et al. (2005) · Circulation · doi:10.1161/01.cir.0000153267.21278.8d · Cited by 447
Self-citation
Cited by
Sorted by citations
Items 801–840 of 840
Dynamic role of hormones on Brugada syndrome phenotype
Vrtikapa, D., Krasowski, A. A., Orland, K. M., & Eckhardt, L. L. (2024) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2024.08.010
Neto, V. D., Correia, J., Costa, A., & Santos, L. (2024) · Cor et Vasa · doi:10.33678/cor.2024.027
Reply to the Editor — Validation and predictive performance of the PAT score
Kamakura, T., Takagi, M., Komatsu, Y., Shinohara, T., Aizawa, Y., Sekiguchi, Y., Yokoyama, Y., Aihara, N., Hiraoka, M., & Aonuma, K. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.10.048
Clinical Management of Inherited Arrhythmias
Moore, B. M., Laksman, Z., Roston, T. M., & Krahn, A. D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00005-4
High-risk electrocardiographic markers for sudden death in Brugada syndrome
Díaz-Tostado, S., Coutiño, H., Moisés Levinstein, J., Márquez-Murillo, M. F., & Brugada, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22344-0.00013-9
COVID-19 infection and exercise reveal the ECG form of Brugada syndrome: A two-case reports
Sdogkos, E., Konstantinou, T., Spahiu, A., & Vogiatzis, I. (2024) · Journal of Health Science Research · doi:10.25259/jhsr_61_2024
Eftekhari, S. S., Hashemizadeh, S. M., Zaeim, H. N., & Barnaji, L. F. (2025) · International Journal of Cardiovascular Practice · doi:10.5812/intjcardiovascpract-160642
Dinatale, A., Crocamo, A., Bearzot, L., Gonzi, G., Barocelli, F., Russo, F., Guidorossi, A., Niccoli, G., & Notarangelo, M. F. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf350
Postema, P. G., Behr, E. R., & Wilde, A. A. M. (2025) · EP Europace · doi:10.1093/europace/euaf116
Self-citationLaporte, P.-L., Vaglio, M., Denjoy, I., Maison‐Blanche, P., Maury, P., Hermida, A., Klug, D., Maltret, A., Badilini, F., Leenhardt, A., et al. (2025) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2025.154081
Management of channelopathies in children
Krause, U. (2025) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-025-01098-2
Abdallah, F., Bun, R. S., Geoffroy, O., Roumegou, P., Payet, F., Wiart, F., Clerici, G., Duchâteau, J., & Churet, M. (2025) · medRxiv · doi:10.1101/2025.08.05.25333081
Chintanavilas, K., Methachittiphan, N., & Apiyasawat, S. (2023) · Asian Medical Journal and Alternative Medicine · doi:10.70933/2773-9465.1080
Russo, V., Caturano, A., Migliore, F., Guerra, F., Francia, P., Nesti, M., Conte, G., Perini, A. P., Mascia, G., Albani, S., et al. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02738-w
Impact of Atrial Fibrillation on the Outcome of Patients with Brugada Syndrome: A Meta-Analysis
Aboutorabi, M., Ahmad, M., Bray, J. J. H., Gomes, D., & Providencia, R. A. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12100391
Devkota, L., Hoffer-Hawlik, M. A., Yang, F., & Jung, A. S. (2025) · Case Reports in Cardiology · doi:10.1155/cric/5536305
Sudden cardiac death in congenital arrhythmogenic syndromes: Risk stratification and management
Rafla, S. M., Nawar, M., Sanhoury, M. I., Dawood, M., Elamin, A., Ahmed, A. A., Zaki, M. A., & Assaad, H. S. (2025) · Heart Vessels and Transplantation · doi:10.24969/hvt.2025.602
Iacopino, S., Sorrenti, P. F., Petretta, A., Colella, J., Vilio, A. D., Statuto, G., Fabiano, G., Campagna, G., Peluso, G., Fabiano, E., et al. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1658355
Barbosa, L., Oliveira, V. M. R., Consoli, L., Pisani, C. F., Darrieux, F., Brugada, J., & Scanavacca, M. (2025) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.70188
ECG Markers of Positive Drug Challenge With Ajmaline in Patients With Brugada Syndrome
Tülümen, E., Kruska, M., Wuerfel, S., Kohl, M., Liebe, V., Akın, İ., Kuschyk, J., Duerschmied, D., Borggrefe, M., & Rudic, B. (2025) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.70137
Self-citationThe Impact of Medical Management on Quality of Life in Brugada Syndrome Patients
Richards, S. (2012) · D-Scholarship@Pitt (University of Pittsburgh)
Chahal, C. A. A., & Landstrom, A. P. (2025) · Springer eBooks · doi:10.1007/978-3-319-66816-1_1221-1
Low Arrhythmic Risk in Individuals With Brugada ECG Pattern and a Negative dST-Tiso Criterion
Iacopino, S., Sorrenti, P. F., Fabiano, G., Campagna, G., Fabiano, E., Petretta, A., Colella, J., Vilio, A. D., Cecchini, E., Indellicati, G., et al. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.02.045
Primäre und sekundäre Prävention des plötzlichen Herztodes
Shamloo, A. S., & Hindricks, G. (2026) · Die Kardiologie · doi:10.1007/s12181-026-00805-8
Shinohara, T., Takagi, M., Kamakura, T., Komatsu, Y., Aizawa, Y., Sekiguchi, Y., Yokoyama, Y., Aihara, N., Hiraoka, M., & Aonuma, K. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.03.004
Ziyadeh-Isleem, A. (2014) · theses.fr (ABES) · doi:10.70675/ead6cb80z8324z43f0z8281zac5495e5661a
Hội chứng Brugada với thi đấu thể thao: diễn biến tự nhiên, phân tầng nguy cơ và khuyến cáo
Phong, P. Đ., & Phong, Đ. V. (2021) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.96.2021.130
Síndrome de Brugada con patrón tipo 2. Reporte de un caso
Arroyo, C., Torre-Gómez, V. A., González, M. A. B., Guzmán‐Priego, C. G., & Baeza‐Flores, G. D. C. (2026) · Cardiovascular and Metabolic Science · doi:10.35366/122890
Lateral Leads Drive Risk Prediction in Brugada Syndrome: A Deep Learning Study
Randazzo, V., Casella, A., Pasero, E. G. A., Giustetto, C., Casu, G., Berne, P., Fancello, T., & Gaïta, F. (2026) · IEEE International Symposium on Medical Measurements and Applications (MeMeA) · doi:10.1109/memea69746.2026.11537375
Self-citationKhoury, F., Kar, S., Yoruk, A., & Afzal, K. (2026) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2026.06.023
Cardiovascular Disorders: Part G—Arrhythmias
Pósán, E. (2026) · Springer eBooks · doi:10.1007/978-3-031-90919-1_26-1
Mureşan, L., Cismaru, G., Popa, S., Roşu, R., Guşetu, G., Puiu, M., Mada, R. O., Muresan, C., Bouar, R. L., Schiau, S., et al. (2026) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-026-00828-2
Yonezu, K., Shinohara, T., Takahashi, M., Hirota, K., Kondo, H., Fukui, A., Akioka, H., Teshima, Y., & Takahashi, N. (2026) · Heart Rhythm O2 · doi:10.1016/j.hroo.2026.09.001
Ahmad, O., Muhammad, H., Rattanawong, P., Alissa, A., Al-Hassnan, Z., Mohty, D., Ghamdi, B. S. A., Echahidi, N., Chugh, S. S., & Shen, W.-K. (2026) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2026.100760
A clinical case of procainamide‑induced Brugada pattern type 1
Borisov, A., Gogolev, V. A., Ammosova, K. A., Lugovskaya, S. R., & Nogovitsyna, S. V. (2026) · Yakut Medical Journal · doi:10.25789/ymj.2026.95.34
Napolitano, C., Pizzetti, C., Kukavica, D., Morini, M., Ottaviano, L., Giordano, U., Memmi, M., Gambelli, P., Mazzanti, A., COPPINI, L., et al. (2026) · EP Europace · doi:10.1093/europace/euag278
Снежицкий, В. А. (2026) · Кардиология в Беларуси · doi:10.34883/pi.2026.18.5.009
Metadata
- Authors
- Probst, V., Veltmann, C., Eckardt, L., Meregalli, P. G., Gaita, F., Tan, H. L., Babuty, D., Sacher, F., Giustetto, C., Schulze-Bahr, E., Borggrefe, M., Haissaguerre, M., Mabo, P., Le Marec, H., Wolpert, C., & Wilde, A. A. M.
- Affiliations
- Inserm (FR)
- From INSERM, UMR915, Nantes, France (V.P., H.L.M.); Université de Nantes, l’institut du thorax, Nantes, France (V.P., H.L.M.); CHU Nantes, l’institut du thorax, Service de cardiologie, Nantes, France (V.P., H.L.M.); First Department of Medicine, Cardiology, University Hospital Mannheim, Mannheim, Germany (C.V., M.B., C.W.); University Hospital of Muenster, Department of Cardiology and Angiology, Muenster, Germany (L.E., E.S.-B.); Department of Cardiology, Academic Medical Center, University of...
- ORCID
- Venue
- Circulation
- Published
- 2010-02-09
- Volume
- 121
- Issue
- 5
- Pages
- 635-643
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2128734390
- Cited by
- 847
- References
- 37
- Citations by year
- 2026: 19 · 2025: 35 · 2024: 42 · 2023: 38 · 2022: 45 · 2021: 46 · 2020: 50 · 2019: 45 · 2018: 55 · 2017: 73 · 2016: 64 · 2015: 60 · 2014: 39 · 2013: 70 · 2012: 75
- FWCI
- 50.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Agence Nationale de la Recherche
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Centre Hospitalier Universitaire de Nantes
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Keywords
- Brugada syndrome, sudden cardiac death, long-term prognosis, asymptomatic patients, syncope, implantable cardioverter-defibrillator shocks, SCN5A mutation, family history of sudden cardiac death
- MeSH terms
- Adult, Death, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prognosis, Registries, Ventricular Fibrillation, Brugada Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
